| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538214 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | US7538115 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/26/2009 | US7538113 6-{4-[2-(4-tert-butyl-phenyl)-1H-imidazo[4,5-c]pyridin-4-yl]-piperazin-1-ylmethyl}quinoxaline; controls biosynthesis and release of sex steroids in the gonads; contraceptive; anticarcinogenic agent; prostate, uterine, breast, ovarian cancer, endometriosis, uterine fibroids, primary hirsutism |
| 05/26/2009 | US7538109 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 05/26/2009 | US7538098 19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2396587C Pyridine ketone herbicide compositions |
| 05/26/2009 | CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists |
| 05/26/2009 | CA2393559C Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 05/26/2009 | CA2354774C Farnesyl protein transferase inhibitors |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009065131A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | WO2009064959A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | WO2009064848A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | WO2009064836A2 Kynurenine-aminotransferase inhibitors |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064449A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 05/22/2009 | WO2009064388A2 Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders |
| 05/22/2009 | WO2009063953A1 Phenylpyrazole derivatives |
| 05/22/2009 | WO2009063821A1 Heteroaryloxy quinazoline derivative |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | WO2009062883A1 Drug active in neuropathic pain |
| 05/22/2009 | WO2009062658A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009010260A3 Condensed anthranilamide insecticides |
| 05/22/2009 | WO2008136815A3 5, 6-ring annulated indole derivatives and use thereof |
| 05/22/2009 | WO2008135671A3 Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 05/22/2009 | WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705562A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/22/2009 | CA2705391A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2703220A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/22/2009 | CA2702874A1 Drug active in neuropathic pain |
| 05/21/2009 | US20090131707 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
| 05/21/2009 | US20090131669 to replace the fragile proteinaceous ion pores currently used for studying DNA translocation; 1,4-bis(4-ethynylpyridine)benzene complexed with bis(trioctylphosphino)-platinum(II)bis(trifluoromethanesulphonate) |
| 05/21/2009 | US20090131666 2-Chloro-N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazoline-4-amine hydrochloride; chemokine receptor modulators; inflammatory diseases such as rheumatism, psoriasis, atopic dermatitis and asthma, allergic diseases, autoimmune diseases |
| 05/21/2009 | US20090131664 Method for Producing 4(3H)-Quinazolinone Derivative |
| 05/21/2009 | US20090131642 Synthetic Nanopores for DNA Sequencing |
| 05/21/2009 | US20090131505 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide |
| 05/21/2009 | US20090131482 Methyl-benzimidazole derivatives |
| 05/21/2009 | US20090131481 Transcription Factor Modulating Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090131478 Growth Hormone Secretagogues |
| 05/21/2009 | US20090131477 New use of iloperidone |
| 05/21/2009 | US20090131470 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 05/21/2009 | US20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 05/21/2009 | US20090131460 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 05/21/2009 | US20090131454 New compounds 067 |
| 05/21/2009 | US20090131448 2-(Piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 05/21/2009 | US20090131444 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| 05/21/2009 | US20090131438 Triazole derivative |
| 05/21/2009 | US20090131436 Pyrimidine Derivatives |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131423 Tyrosine Kinase Inhibitors |
| 05/21/2009 | US20090131417 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131412 Novel 2-quinolone derivative |
| 05/21/2009 | US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 05/21/2009 | US20090131403 Nitrogenated heterocyclic derivative , and pharmaceutical agent comprising the derivative as active ingredient |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2009 | US20090131382 Treatment of rheumatoid arthritis using imatinib |
| 05/21/2009 | US20090130367 Cationic compound, dye compound and method of using the same, and optical information recording medium |
| 05/21/2009 | US20090130209 Novel Pyridazinone Derivatives |
| 05/21/2009 | US20090130117 Substituted Tetrazole Compounds and Uses Thereof |
| 05/21/2009 | US20090130097 Quinazolinone Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/21/2009 | US20090130024 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels |
| 05/21/2009 | US20090128013 arylaton and acylation of 2,5-dimethyl-1,4-phenylenediamine; emits blue light with high color purity, high electrical stability; for high efficiency, low driving voltage, high brightness, and long lifetime devices |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | EP2060569A1 Ethyl 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulfonate hemihydrate and its use as a medicament |
| 05/20/2009 | EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2059518A2 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 05/20/2009 | EP2059517A1 Pyrimidine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059516A1 Pyridine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059515A2 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| 05/20/2009 | EP2059508A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 05/20/2009 | EP2059507A2 Ep2 agonists |
| 05/20/2009 | EP2059502A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/20/2009 | EP1607091B1 Antihepatitis c virus agent and anti-hiv agent |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1534686B1 Nf-kb inhibitors and uses thereof |